Montuerto, Jelly E.

HRN: 13-13-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 1.5GM (VIAL)
06/22/2025
06/29/2025
IV
1.5g
Q8
Cholecystitis
Remove - Pending Acceptance
06/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2025
06/29/2025
IV
500MG
Q8
Cholecystitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: